nektar therapeutics

nektar therapeutics

NASDAQ:NKTR

Chart

Detailed Quote

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India.
Featured Articles and Interviews
Large pharmaceutical pill with gold dollar sign in the middle. Stock tickers and charts are in the background.

Top 5 NASDAQ Pharma Stocks (Updated July 2024)

Press Releases

/UPDATE -- Nektar Therapeutics/

New Rezpegaldesleukin Data Supporting Long-term Durability and Disease Improvement in Patients with Alopecia Areata and Atopic Dermatitis at EADV Congress 2026

New Biomarker Data Presented in a Late Breaking Oral Presentation at EADV Congress 2026 Showing Early Molecular Responses to Rezpegaldesleukin Across Multiple Immune Pathways Dysregulated in Patients with Atopic Dermatitis

The Conversation (0)